Friday, 4 January 2019

Bristol-Myers: Analysis On Celgene Deal - Seeking Alpha

Posted by hamad on 00:09 No comments
  1. Bristol-Myers: Analysis On Celgene Deal  Seeking Alpha
  2. Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies  CNBC
  3. Advances in Cancer Drugs Fuel Blockbuster Deal  The Wall Street Journal
  4. Here’s What Celgene Shareholders Are Getting From Bristol-Myers Squibb  Motley Fool
  5. Don’t Let Bristol-Myers’s Megamerger Fool You  Bloomberg
  6. View full coverage on Google News


from Top stories - Google News http://bit.ly/2CP4l3O

No comments :

Post a Comment

Subscribe to: Post Comments ( Atom )

Recent Posts

Like us

Contact

Name

Email *

Message *